Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05218343 · ClinicalTrials.gov registry record · NA
An Intuitive, Non-intrusive, Approach to Reduce Patient Harm From Inappropriate Dosing of High-risk Drugs in Older Adult Patients Across an Urban Safety Net Hospital System
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 8,640
- Enrollment target
NCT05218343 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 8,640 participants.
The verdict
NCT05218343, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 8,640 participants
- Enrollment target
Study Summary
This study will assess whether a modification in the default dose and frequency (the first option a provider sees) during electronic prescribing of a high-risk drug can impact prescribing behavior and subsequent changes in average dose for the targeted high-risk drug, when prescribed to a hospitalized patient aged ≥65 years. In this cluster randomized crossover (CRXO) trial we will randomize a non-intrusive "nudge" intervention, which involves modifying the default dose for high-risk drugs when prescribed electronically to hospitalized patients aged ≥65 years. The CRXO trial involves 10 sites in an urban health system: five sites will start the trial under the intervention/control during a first time period (T1) after which they switch intervention/control status (T2). The primary outcome is prescription rate of a lower default dose (i.e. the geriatric standard) for 8 high-risk drugs. This study will inform the effectiveness of EHR-based "nudge" interventions to reduce inappropriate prescribing of high-risk drugs for elderly patients. Analyses ongoing, expected to finalize spring 2023
Interventions
- BEHAVIORAL EHR-based "nudge" interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,640 participants |
| Start Date | 2022-02-16 |
| Est. Completion | 2022-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05218343
The ClinicalTrials.gov registry entry for NCT05218343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8,640 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EHR-based "nudge" interventions is the first listed.
NCT05218343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05218343 about?
NCT05218343 is a clinical study titled "An Intuitive, Non-intrusive, Approach to Reduce Patient Harm From Inappropriate Dosing of High-risk Drugs in Older Adult Patients Across an Urban Safety Net Hospital System". This study will assess whether a modification in the default dose and frequency (the first option a provider sees) during electronic prescribing of a high-risk drug can impact prescribing behavior and subsequent changes in average dose for the targeted high-risk drug, when prescribed to a hospitaliz...
What is the current status of trial NCT05218343?
This trial is currently completed. It is a NA study. The enrollment target is 8,640 participants. The study started on 2022-02-16. Estimated completion is 2022-08-02.
What interventions are being tested in trial NCT05218343?
The interventions under investigation include: EHR-based "nudge" interventions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05218343?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.